The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor

Nerve growth factor is a therapeutic candidate for Alzheimer’s disease. Due to its pain-inducing activity, in current clinical trials nerve growth factor is delivered locally into the brain by neurosurgery, but data on the efficacy of local nerve growth factor delivery in decreasing amyloid-β deposi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Brain
Auteurs principaux: Capsoni, Simona, Malerba, Francesca, Carucci, Nicola Maria, Rizzi, Caterina, Criscuolo, Chiara, Origlia, Nicola, Calvello, Mariantonietta, Viegi, Alessandro, Meli, Giovanni, Cattaneo, Antonino
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379860/
https://ncbi.nlm.nih.gov/pubmed/28031222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/aww271
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires